SSS.V Will Be $1 Soon
posted on
Jan 24, 2010 12:17PM
Stem Cell is a public biotechnology company focused on the development and commercialization of drug-based therapies to treat central nervous system diseases.
Hi everyone, I have held shares in Stem Cell Therapeutics for almost a year. I started buying in @ .08 cents and have built on my position considerably since then after doing more intense Due Diligence!
I was in attendance for the Nov 26 'From the Lab to the Bedside' seminar and it was very informative w/a full house!
Q1 10
|
Complete patient enrollment in modified REGENESIS Phase IIb acute ischemic stroke trial
|
Q2 10
|
Report Top-line modified REGENESIS Phase IIb stroke trial data
|
H1 10
|
Initiate and enrol patients in a Phase IIa clinical study for traumatic brain injury
|
H2 10
|
Initiate clinical Proof-of-Concept study for multiple sclerosis
|
H2 10
|
Complete preclinical study for hemorrhagic stroke
|
H2 10
|
Complete 'end of Phase II' meeting with the FDA prior to initiating the Phase III stroke trial
|